
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Troy Trygstad, PharmD, MBA, PhD, of Community Care of North Carolina, talks about how accountable pharmacists are for quality.
Troy Trygstad, PharmD, MBA, PhD, of Community Care of North Carolina, talks about how accountable pharmacists are for quality.
This video was recorded at APhA's 2015 annual meeting.






